blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2170055

EP2170055 - COMPOSITION FOR USE IN TREATING CONNECTIVE TISSUE DAMAGE [Right-click to bookmark this link]
Former [2010/14]COMPOSITION AND METHOD FOR TREATING CONNECTIVE TISSUE DAMAGE
[2023/02]
StatusNo opposition filed within time limit
Status updated on  10.05.2024
Database last updated on 19.10.2024
FormerThe patent has been granted
Status updated on  02.06.2023
FormerGrant of patent is intended
Status updated on  22.01.2023
FormerExamination is in progress
Status updated on  12.12.2017
Most recent event   Tooltip02.08.2024Lapse of the patent in a contracting state
New state(s): SI		published on 04.09.2024  [2024/36]
Applicant(s)For all designated states
Arthrodynamic Holdings, LLC
100 S Main Street
Versailles, KY 40383-1214 / US
[2023/48]
Former [2017/38]For all designated states
Arthrodynamic Holdings, LLC
2333, Alexandria Drive
Lexington, KY 40504 / US
Former [2010/14]For all designated states
Arthrodynamic Technologies, Animal Halth Division, Inc.
P.O. Box 516
Lexington, KY 40588 / US
Inventor(s)01 / MARCUM, Frank, D.
100 South Main Street
Versailles, KY 40383 / US
02 / SEANOR, John, William
3409 Montavesta Road
Lexington, KY 40502 / US
03 / NORTHROP, Foster, Harold
2301 Halls Hill Road
Crestwood, KY 40014 / US
 [2010/14]
Representative(s)Weickmann & Weickmann PartmbB
Postfach 860 820
81635 München / DE
[N/P]
Former [2023/27]Weickmann & Weickmann PartmbB
Postfach 860 820
81635 München / DE
Former [2010/14]Weiss, Wolfgang, et al
Weickmann & Weickmann Patentanwälte Postfach 86 08 20
81635 München / DE
Application number, filing date08771608.020.06.2008
[2010/14]
WO2008US67688
Priority number, dateUS2007076651021.06.2007         Original published format: US 766510
[2010/14]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008157767
Date:24.12.2008
Language:EN
[2008/52]
Type: A1 Application with search report 
No.:EP2170055
Date:07.04.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 24.12.2008 takes the place of the publication of the European patent application.
[2010/14]
Type: B1 Patent specification 
No.:EP2170055
Date:05.07.2023
Language:EN
[2023/27]
Search report(s)International search report - published on:US24.12.2008
(Supplementary) European search report - dispatched on:EP31.08.2010
ClassificationIPC:A61K31/7008, A61K31/728, A61K31/736, A61P19/04, A61P19/08, A61P43/00
[2022/51]
CPC:
A61K31/737 (EP,US); A61K31/56 (EP,US); A61K31/7008 (EP,US);
A61K31/715 (EP,US); A61K31/728 (EP,US); A61K35/12 (EP,US);
A61K38/18 (EP,US); A61K45/06 (US); A61L15/20 (US);
A61L15/225 (EP,US); A61L15/28 (US); A61L15/44 (US);
A61L17/10 (EP,US); A61L27/26 (EP,US); A61P19/00 (EP);
A61P19/02 (EP); A61P19/04 (EP); A61P19/08 (EP);
A61P29/00 (EP); A61P37/02 (EP); A61P37/06 (EP);
A61P43/00 (EP); A61P7/00 (EP); A61B17/06166 (EP,US);
A61B17/064 (EP,US); A61B2017/00004 (EP,US); A61L2300/232 (US);
A61L2300/236 (US) (-)
C-Set:
A61K38/18, A61K2300/00 (US,EP);
A61L15/225, C08L5/08 (EP,US);
A61L27/26, C08L5/08 (US,EP)
Former IPC [2010/39]A61K31/715, A61K31/70, A61K31/728, A61P19/00, A61P19/02, A61P19/04
Former IPC [2010/14]A01N43/04, A61K31/715, A61K31/70
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2023/27]
Former [2010/14]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:ZUSAMMENSETZUNG IN DER VERWENDUNG ZUR BEHANDLUNG VON BINDEGEWEBSSCHÄDEN[2023/02]
English:COMPOSITION FOR USE IN TREATING CONNECTIVE TISSUE DAMAGE[2023/02]
French:COMPOSITION POUR L'UTILISATION DANS LE TRAITEMENT DE LÉSIONS DU TISSU CONJONCTIF[2023/02]
Former [2010/14]ZUSAMMENSETZUNG UND VERFAHREN ZUR BEHANDLUNG VON BINDEGEWEBSSCHÄDEN
Former [2010/14]COMPOSITION AND METHOD FOR TREATING CONNECTIVE TISSUE DAMAGE
Former [2010/14]COMPOSITION ET MÉTHODE DE TRAITEMENT DE LÉSIONS DU TISSU CONJONCTIF
Entry into regional phase20.01.2010National basic fee paid 
20.01.2010Search fee paid 
20.01.2010Designation fee(s) paid 
20.01.2010Examination fee paid 
Examination procedure20.01.2010Examination requested  [2010/14]
24.02.2011Amendment by applicant (claims and/or description)
16.08.2012Despatch of a communication from the examining division (Time limit: M04)
18.10.2012Reply to a communication from the examining division
11.12.2012Despatch of a communication from the examining division (Time limit: M06)
18.06.2013Reply to a communication from the examining division
15.12.2015Despatch of a communication from the examining division (Time limit: M04)
19.04.2016Reply to a communication from the examining division
30.11.2017Despatch of a communication from the examining division (Time limit: M04)
28.02.2018Reply to a communication from the examining division
30.01.2019Despatch of a communication from the examining division (Time limit: M06)
30.07.2019Reply to a communication from the examining division
09.04.2020Despatch of a communication from the examining division (Time limit: M04)
23.07.2020Reply to a communication from the examining division
23.01.2023Communication of intention to grant the patent
11.05.2023Fee for grant paid
11.05.2023Fee for publishing/printing paid
11.05.2023Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  16.08.2012
Opposition(s)08.04.2024No opposition filed within time limit [2024/24]
Fees paidRenewal fee
30.06.2010Renewal fee patent year 03
31.05.2011Renewal fee patent year 04
29.06.2012Renewal fee patent year 05
28.03.2013Renewal fee patent year 06
30.05.2014Renewal fee patent year 07
29.05.2015Renewal fee patent year 08
31.03.2016Renewal fee patent year 09
31.05.2017Renewal fee patent year 10
02.07.2018Renewal fee patent year 11
01.07.2019Renewal fee patent year 12
30.06.2020Renewal fee patent year 13
31.05.2021Renewal fee patent year 14
30.06.2022Renewal fee patent year 15
31.05.2023Renewal fee patent year 16
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT05.07.2023
CZ05.07.2023
DK05.07.2023
EE05.07.2023
FI05.07.2023
HR05.07.2023
LT05.07.2023
LV05.07.2023
NL05.07.2023
PL05.07.2023
RO05.07.2023
SE05.07.2023
SI05.07.2023
SK05.07.2023
NO05.10.2023
GR06.10.2023
IS05.11.2023
[2024/36]
Former [2024/23]AT05.07.2023
CZ05.07.2023
DK05.07.2023
EE05.07.2023
FI05.07.2023
HR05.07.2023
LT05.07.2023
LV05.07.2023
NL05.07.2023
PL05.07.2023
RO05.07.2023
SE05.07.2023
SK05.07.2023
NO05.10.2023
GR06.10.2023
IS05.11.2023
Former [2024/22]AT05.07.2023
CZ05.07.2023
DK05.07.2023
FI05.07.2023
HR05.07.2023
LT05.07.2023
LV05.07.2023
NL05.07.2023
PL05.07.2023
RO05.07.2023
SE05.07.2023
NO05.10.2023
GR06.10.2023
IS05.11.2023
Former [2024/10]AT05.07.2023
FI05.07.2023
HR05.07.2023
LT05.07.2023
LV05.07.2023
NL05.07.2023
PL05.07.2023
SE05.07.2023
NO05.10.2023
GR06.10.2023
IS05.11.2023
Former [2024/09]AT05.07.2023
FI05.07.2023
LT05.07.2023
NL05.07.2023
SE05.07.2023
NO05.10.2023
GR06.10.2023
IS05.11.2023
Former [2024/08]LT05.07.2023
NL05.07.2023
NO05.10.2023
GR06.10.2023
Former [2024/05]NL05.07.2023
Documents cited:Search[Y]US2003069171  (PETITO GEORGE D [US], et al) [Y] 1-19 * claim 1 *;
 [X]WO2004034980  (MARCUM FRANK D [US]) [X] 1-19 * claims 1-36 *;
 [X]US2004092479  (MARCUM FRANK D [US]) [X] 1-19 * claims 1-36 * * paragraph [[0057]] *;
 [X]US2006234978  (MARCUM FRANK D [US]) [X] 1-19 * paragraph [[0032]] * * paragraph [[0060]] *;
 [X]EP1762247  (NUTRAMAX LAB INC [US]) [X] 1-19* claims 1, 3, 6, 11 *;
 [Y]  - "P196 Comparison between glucosamine with chondroitin sulfate and glucosamine with chondroitin sulfate and hyaluronate for symptoms of knee osteoarthritis", OSTEOARTHRITIS AND CARTILAGE, BAILLIERE TINDALL, LONDON, GB, (20050101), vol. 13, ISSN 1063-4584, page S99, XP005208707 [Y] 1-19 * abstract *
International search[X]US2003216348  (HENDERSON ROBERT W [US], et al);
 [Y]US2004253212  (KOIWAI KAZUNORI [JP], et al);
 [Y]US2006045872  (MIGUEL MARIA GEMA F [ES], et al)
ExaminationGB2317109
    - AMIEL D ET AL, "Hyaluronan in flexor tendon repair", THE JOURNAL OF HAND SURGERY, W.B. SAUNDERS, AMSTERDAM, NL, vol. 14, no. 5, ISSN 0363-5023, (19890901), pages 837 - 843, (19890901), XP027055622
by applicantUS4216204
 US4782046
 US4808576
 US4837024
 US5141928
 US5442053
 US5466823
 GB2317109
 US5756529
 US5840715
 US5922692
 US5929050
 US6127356
 US6534693
 US2003069171
 US2003216348
 WO2004034980
 US2004092479
 US2004253212
 US2006045872
 US2006234978
 EP1762247
    - "P]96 Comparison between glucosamine with chondroitin sulfate and glucosamine with chondroitin sulfate and hyaluronate for symptoms of knee osteoarthritis", BUCCI et al., Osteoarthritis and Cartilage, Bailliere Tindall, (20050000), vol. 13
    - AMIEL et al., "Hyaluronan in flexor tendon repair", The Journal of Hand Surgery, (19890900), vol. 14A, no. 5, pages 837 - 843
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.